Company has already raised $24m and now hopes to develop drug delivery technology through flotation, writes Gavin Daly.
Merrion Pharmaceuticals, the Dublin Firm that plans to list in Ireland and the US next month, is betting on investor interest in the potential of its drugs.
The company has a limited trading history, with turnover of just over $200,000 (€150,000) from the time it was founded in December 2003 to the end of September last year.
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Team Pass
Get a Business Account for you and your team